Cercar
05/07/2023
Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS)
Oteo-Álvaro Á., García C.G., Sánchez A.I., Santamaria C.A., de Diego-Adeliño J.. Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS). OSTEOPOROSIS INTERNATIONAL. 2023; 34(10)DOI:10.1007/s00198-023-06838-z. PMID:37405407. IF:4.200(Q1/3D).
05/07/2023
Psychometric validation of the 15-item Questionnaire about the Process of Recovery in Spain (QPR-15-SP)
Goodman-Casanova J.M., Cuesta-Lozano D., Alupoaei C., Bello, EMG, Herrera-Imbroda J., Mayoral-Cleries F., Guzman-Parra J.. Psychometric validation of the 15-item Questionnaire about the Process of Recovery in Spain (QPR-15-SP). Frontiers in Psychology. 2023; 14DOI:10.3389/fpsyg.2023.1178341. PMID:37484089. IF:2.600(Q2/3D).
01/07/2023
Massive Neonatal Arterial Ischemic Stroke
Arca, G, Nunez, C, Stephan-Otto, C, Arnaez, J, Agut, T, Cordeiro, M, Boronat, N, Lubian-Lopez, S, Benavente-Fernandez, I, Valverde, E, Garcia-Alix, A. Massive Neonatal Arterial Ischemic Stroke. PEDIATRIC NEUROLOGY. 2023; 144DOI:10.1016/j.pediatrneurol.2023.03.013. PMID:37087915. IF:3.200(Q1/2D).
01/07/2023
Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort
Segura, AG, Mane, A, Prohens, L, Rodriguez, N, Mezquida, G, Cuesta, MJ, Vieta, E, Amoretti, S, Lobo, A, Gonzalez-Pinto, A, Diaz-Caneja, CM, Bejarano, AR, Jimenez, E, Baeza, I, Legido, T, Saiz-Ruiz, J, Bernardo, M, Mas, S. Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort. PSYCHIATRY RESEARCH. 2023; 325DOI:10.1016/j.psychres.2023.115249. PMID:37178502. IF:4.200(Q1/2D).
13/06/2023
Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: differences between males and females (vol 13, 982583, 2022)
Serra-Navarro M., Amoretti S., Verdolini N., Forte M.F., Sánchez-Torres A.M., Vieta E., Clougher D., Lobo A., González-Pinto A., Panadero R., Roldán A., Carvalho A.F., de la Serna E., Toll A., Ramos-Quiroga J.A., Torrent C., Cuesta M.J., Bernardo M., PEPs Grp. Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: differences between males and females (vol 13, 982583, 2022). Frontiers in Psychiatry. 2023; 14DOI:10.3389/fpsyt.2023.1200313. PMID:37383614. IF:3.200(Q2/4D).
31/05/2023
Pharmacological Management of Borderline Personality Disorder and Common Comorbidities
Pascual, JC, Arias, L, Soler, J. Pharmacological Management of Borderline Personality Disorder and Common Comorbidities. CNS DRUGS. 2023; 37(6)DOI:10.1007/s40263-023-01015-6. PMID:37256484. IF:7.400(Q1/1D).
16/05/2023
Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practice
Fraguas D., Almenta Gallego D., Arques-Egea S., Gómez-Revuelta M., Sánchez-Lafuente C.G., Hernández Huerta D., Núñez Arias D., Oda Plasencia-García B., Parro Torres C., Romero-Guillena S.L., Ros Cucurul E., Alamo C.. Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practice. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE. 2023; 27(1)DOI:10.1080/13651501.2022.2064308. PMID:35792729. IF:2.900(Q2/4D).
04/05/2023
Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis
Valli, I, Segura, AG, Verdolini, N, Garcia-Rizo, C, Berge, D, Baeza, I, Cuesta, MJ, Gonzalez-Pinto, A, Lobo, A, Martinez-Aran, A, Mezquida, G, Pina-Camacho, L, Bejarano, AR, Mas, S, McGuire, P, Bernardo, M, Vieta, E, PEPs Grp. Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis. ACTA PSYCHIATRICA SCANDINAVICA. 2023; 148(1)DOI:10.1111/acps.13546. PMID:36912272. IF:5.300(Q1/2D).